Top 50 Medical Device Startup Investors in United Kingdom (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Parkwalk Advisors
VC Fund
|
22 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $1.1M–$46M |
|
SFC Capital
VC Fund
|
20 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $127k–$2M |
|
Archangels
VC Fund
|
16 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $1.3M–$8.3M |
|
Scottish Enterprise
VC Fund
|
16 | United Kingdom, United States, Switzerland | Grant, Seed | Biotechnology, Software, Health Care | $119k–$4.3M |
|
Mercia Fund Managers
VC Fund
|
15 | United Kingdom, United States, Hungary | Seed, Series A | Software, Health Care, Biotechnology | $196k–$14M |
|
UK Innovation & Science Seed Fund
VC Fund
|
13 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical | $458k–$14M |
|
Newable Private Investing
VC Fund
|
12 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.2M |
|
Northstar Ventures
VC Fund
|
12 | United Kingdom, United States, Indonesia | Seed, Series A | Software, Health Care, E-Commerce | $39k–$10M |
|
SOSV
VC Fund
|
12 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
SyndicateRoom
VC Fund
|
11 | United Kingdom, United States, India | Seed, Equity Crowdfunding | Health Care, Software, Medical | $244k–$2.6M |
|
Mercia Asset Management
VC Fund
|
10 | United Kingdom, United States | Series A, Seed | Software, Health Care, Information Technology | $1.1M–$13M |
|
Oxford Technology Management
VC Fund
|
10 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $33k–$7.9M |
|
Scottish Investment Bank
VC Fund
|
10 | United Kingdom, United States, France | Seed, Series A | Software, Biotechnology, Health Care | $327k–$7M |
|
Development Bank of Wales
VC Fund
|
10 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Biotechnology | $18k–$4.1M |
|
Deepbridge Capital
VC Fund
|
9 | United Kingdom, Australia, Singapore | Seed, Series A | Health Care, Biotechnology, Medical | $152k–$15M |
|
Catapult Ventures
VC Fund
|
9 | United Kingdom, United States, Israel | Seed, Series A | Health Care, Biotechnology, Medical | $150k–$26M |
|
Longwall Venture
VC Fund
|
8 | United Kingdom, Germany, Philippines | Seed, Series A | Biotechnology, Health Care, Medical Device | $637k–$16M |
|
Innovate UK
VC Fund
|
8 | United Kingdom, United States, Ireland | Grant, Seed, Pre-Seed | Health Care, Biotechnology, Software | $58k–$3.7M |
|
Kelvin Capital
VC Fund
|
8 | United Kingdom, United States | Seed, Series A | Health Care, Biotechnology, Manufacturing | $144k–$25M |
|
Midven
VC Fund
|
7 | United Kingdom, United States, Israel | Seed, Series A | Software, Manufacturing, Information Technology | $152k–$2M |
|
Empirical Ventures
VC Fund
|
7 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | $921k–$5.1M |
|
Techstart Ventures
VC Fund
|
7 | United Kingdom, Ireland, United States | Seed, Pre-Seed | Software, Information Technology, Health Care | $100k–$3.9M |
|
The FSE Group
VC Fund
|
6 | United Kingdom, United States, Canada | Seed, Debt Financing | Software, Manufacturing, Information Technology | $111k–$2.6M |
|
IP Group
VC Fund
|
6 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$23M |
|
Business Growth Fund
VC Fund
|
6 | United Kingdom, Ireland, United States | Venture - Series Unknown, Series A | Software, Information Technology, Health Care | $3.2M–$22M |
|
Meridian Health Ventures
VC Fund
|
6 | United Kingdom, Sweden, Germany | Seed, Series A | Health Care, Medical Device, Medical | $1.4M–$23M |
|
Oxford Investment Consultants LLP
VC Fund
|
6 | United Kingdom | Series A, Seed | Software, Health Care, Biotechnology | $982k–$33M |
|
Clarendon Fund Managers
VC Fund
|
6 | United Kingdom, United States, Ireland | Seed, Pre-Seed | Software, Health Care, Biotechnology | $440k–$2.6M |
|
Eos
VC Fund
|
6 | United Kingdom, Ireland, United States | Seed, Series A | Biotechnology, Health Care, Medical | $1.4M–$47M |
|
British Design Fund
VC Fund
|
5 | United Kingdom, Germany | Seed, Pre-Seed, Venture - Series Unknown | Manufacturing, Health Care, Medical Device | $131k–$1.3M |
|
Nesta Ventures
VC Fund
|
5 | United Kingdom, United States | Seed, Series A | Biotechnology, Medical Device, Medical | $982k–$26M |
|
North East Fund
VC Fund
|
5 | United Kingdom, United States | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Biotechnology, Wellness | $338k–$8.6M |
|
TRICAPITAL
VC Fund
|
5 | United Kingdom, France | Seed, Series B | Biotechnology, Software, Health Care | |
|
Antler
VC Fund
|
5 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $108k–$28M |
|
Angels in MedCity
VC Fund
|
5 | United Kingdom, United States | Seed, Angel | Health Care, Biotechnology, Medical | $458k–$880k |
|
New Wave Ventures
VC Fund
|
4 | United Kingdom, France, Australia | Series A, Seed | Medical, Health Care, Internet | $786k–$414M |
|
Barwell Plc
VC Fund
|
4 | United Kingdom | Series A, Series B | Software, Health Care, Biotechnology | $1.7M–$6.4M |
|
Wren Capital
VC Fund
|
4 | United Kingdom | Seed, Series A | Biotechnology, Health Care, Medical | $1.1M–$32M |
|
The North West Fund
VC Fund
|
4 | United Kingdom, United States | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $131k–$4.1M |
|
VentureFounders
VC Fund
|
4 | United Kingdom, United States | Series A, Series B | Health Care, Medical, Software | $643k–$25M |
|
Midlands Engine Investment Fund
VC Fund
|
4 | United Kingdom, United States, Portugal | Debt Financing, Seed | Software, Health Care, Manufacturing | $262k–$2.6M |
|
Wealth Club
VC Fund
|
4 | United Kingdom, United States | Seed, Series A | Health Care, Medical, Medical Device | $1.1M–$14M |
|
Tern
VC Fund
|
4 | United Kingdom, United States | Seed, Convertible Note | Software, Information Technology, Medical | $364k–$1.4M |
|
SIS Ventures
VC Fund
|
4 | United Kingdom | Seed, Series A | Biotechnology, Health Care, Medical | $1.1M–$19M |
|
Angels 5K
VC Fund
|
4 | United Kingdom | Seed, Angel | Biotechnology, Software, Medical | $79k–$1.3M |
|
Oxford Science Enterprises
VC Fund
|
4 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.3M–$168M |
|
BGF Ventures
VC Fund
|
4 | United Kingdom, United States, Ireland | Series A, Series B | Health Care, Biotechnology, Software | $3.3M–$45M |
|
Octopus Ventures
VC Fund
|
4 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Health Care, Information Technology | |
|
Salica
VC Fund
|
4 | United Kingdom, United States, Germany | Seed, Series A, Secondary Market | Software, Information Technology, Health Care | $700k–$21M |
|
Downing Ventures
VC Fund
|
3 | United Kingdom, United States, Israel | Series A, Seed | Software, Health Care, Information Technology | $550k–$13M |
| Access all 765 investors in United Kingdom Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 277
- Round size: Seed $1.1M–$5M; Series A $1.6M–$13M; Series B $2M–$46M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
- Psyomics — Technology to support better mental health assessment - accelerating patients to the right care pathway, first time.
- PredictImmune — Pragmatic play menciptakan demo slot x500 yang merupakan slot online gratis. Nikmati slot demo pragmatic gacor gampang menang di demo pragmatic jamin gacor.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 489
- Round size: Seed $127k–$2M; Pre-Seed $164k–$839k
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Neubond — Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation.
- Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
- Traknova — Traknova provides an AI-powered fleet management platform that helps companies track, manage, and protect vehicles and mobile assets. The platform offers real-time GPS tracking, live monitoring, and telematics data to give operators constant visibility over fleet movements and status. Users can access an intuitive dashboard with historical tripinformation, engine status, and alerts for events such as geofence breaches or unauthorized use. Traknova also supports integrated hardware, including tracking devices and online cameras, to strengthen asset security and streamline recovery when issues arise. The system is designed for fleets across industries, such as service businesses and vehicle rental operators, that need clearer scheduling, better time management, and improved operational control. By consolidating these tools into one platform, Traknova enables data-led fleet planning and day-to-day decision-making.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.3M–$3.9M; Series A $1.6M–$8.3M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
- Bioliberty — Engineering the future of physical and occupational therapy.
- Earth Blox — Earth Blox is a paradigm shift for teaching Earth observation skills to everyone from children to university students & professionals.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 362
- Round size: Seed $375k–$3.9M; Grant $119k–$4.3M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Cumulus Oncology — Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need. We target key pathways to improve the efficacy and outcomes of current and experimental therapies. Cumulus has the backing of a successful entrepreneur in the oncology field and is led by a team of senior professionals and industry partners fromacross the drug discovery and development sector. Together, we offer a wealth of experience and deep insights into optimum approaches for improved cancer patient outcomes.
- Smart Green Shipping — smart green shipping alliance. economically, socially and environmentally superior shipping solutions.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 136
- Round size: Seed $196k–$2M; Series A $2M–$14M
- Lead/follow: 67% lead, 33% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Sen — Sen's vision is to democratize space using video to inform, educate, inspire and benefit all humanity. Sen's mission is to stream real-time videos from space to billions of people, gathering news and information about Earth and space and making it universally accessible.
- Gentronix — Gentronix is a contract research organisation (CRO) providing a wide range of screening and safety services, including genetic toxicology screening and regulatory genotoxicity studies.
- Haystack — Giving techies the tools to uncover, explore and discover the tech landscape with full anonymity - showcasing opportunities that match their interests, values and tech stack.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 136
- Round size: Seed $458k–$5.9M; Series A $2.9M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- MFX — MFX is a platform designed to accelerate the development and manufacturing of cell and gene therapies.
- Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 103
- Round size: Seed $196k–$3.9M; Series A $1.3M–$5.2M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- NuVision — NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham.
- RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 199
- Round size: Seed $39k–$2.2M; Series A $851k–$10M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
- NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
- MySalesCoach — MySalesCoach offers Despite overwhelming evidence that sales coaching has the greatest impact on rep development and success, managers typically devote less than 5% of their time to coaching a team that craves and deserves coaching to reach their full potential.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Equity Crowdfunding
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 139
- Round size: Seed $360k–$2.6M; Equity Crowdfunding $244k–$1.6M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- ManaMind — ManaMind is an AI-powered platform that automates video game quality assurance (QA) testing using autonomous bots to help developers identify bugs faster and cheaper.
- Xperiome — Match research-ready members to clinical and real-world studies, faster and smarter than ever before through data-driven insights into the rare disease experience.
- Joyvié — Joyvié Health designs medical continence products focused on managing severe faecal incontinence. The company is developing a patent-pending class of non-invasive faecal management briefs that prevent stool from contacting the skin. By separating waste from the body, the underwear aims to lower the risk of skin breakdown and secondary infectionwhile reducing the physical and emotional strain on caregivers. Joyvié Health works with care providers to pilot its products in real-world care environments and gather clinical and user feedback. Its offering is intended for adults with continence needs in institutional and home care settings, and for professionals responsible for continence care. The company also engages with investors and partners to advance product development and clinical evaluation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 66
- Round size: Seed $1.1M–$3.1M; Series A $4.8M–$13M
- Lead/follow: 65% lead, 35% follow
Portfolio highlights
- Netacea — Netacea takes a smarter approach to bot management. Intent Analytics™ powered by machine learning quickly and accurately distinguishes bots from humans to protect websites, mobile apps and APIs from automated threats while prioritising genuine users. Actionable intelligence with data-rich visualisations empowers you to make informed decisions aboutyour traffic. The Netacea approach offers incredible speed, accuracy and transparency, solving the growing problem of credential stuffing and account takeover at scale. The technology is designed to complement existing controls such as WAF rulesets, rate limiting and threat databases to provide a deep analysis of all website visitors, actionable intelligence and real-time threat.The Netacea approach continuously monitors your web traffic to pinpoint the difference in automated bot activity vs genuine visitors, keeping you ahead of evolving bot threats. Choose to automatically block, redirect or challenge automated attacks in real-time, or receive alerts notifying you of potential threats. With access to rich dashboards and data, you can easily identify and stop account takeover attempts early in the attack chain.Learn more at www.netacea.com
- Camena Bioscience — Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
- Warwick Acoustics Ltd — Warwick Acoustics is a UK-based technology company specialising in the development of HighRes Audio solutions for the automotive and headphone markets based on its patented High Precision Electrostatic Laminate technology (HPELs). Their ultra thin, lightweight HPELs deliver audiophile performance across a bandwidth several octaves greater thantraditional moving coil speakers in a form factor that is less than one quarter the weight, and one tenth of the thickness. In addition, HPELs offer designers unparalleled flexibility to shaped and form a speaker to individual design requirements.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 109
- Round size: Seed $33k–$2.1M; Series A $786k–$7.9M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 208
- Round size: Seed $327k–$3.1M; Series A $1.6M–$7M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 238
- Round size: Seed $360k–$3.3M; Debt Financing $18k–$4.1M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $25M in 2018
Portfolio highlights
- Forth — Forth are a group of clinical and digital experts who are passionate about healthcare. They’re part of a new breed of digital healthcare companies who are transforming people’s relationship with their health by using technology to give them more information and help them gain greater control.
- Design and Supply — Design and Supply provides products and services primarily for the construction industry, offering Jansen-certified products and British SBD solutions. The company manufactures and supplies items, including steel doors. Additionally, Design and Supply caters to design enthusiasts by offering artwork, fine furniture, antiques, and decor.
- Reacta Healthcare — Reacta Healthcare develops diagnostic solutions and challenge meals for food allergy testing and clinical research.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Australia, Singapore
Investor stats
- Total investments: 86
- Round size: Seed $152k–$2.6M; Series A $2M–$15M
- Lead/follow: 72% lead, 28% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- HeadBox — HeadBox connects corporate event planners with 100,000+ unique, inspiring, iconic, and creative spaces worldwide for meetings and events.
- Touch Biometrix — Welcome at Touch Biometrix. Find out more about The Future of Fingerprint Biometrics!
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Series A $1.6M–$26M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.
Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: United Kingdom, Germany, Philippines
Investor stats
- Total investments: 47
- Round size: Seed $637k–$5.6M; Series A $2.4M–$16M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $101M in 2017
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- Kinomica — Kinomica is a proteomic-data science and diagnostics company specializing in cell signalling. Kinomica offers KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage.
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Grant, Seed, Pre-Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 763
- Round size: Seed $367k–$3.7M; Grant $62k–$1.8M; Pre-Seed $58k–$1.5M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- Icaruus —
- ProtectBox — Cybersecurity award-winning NetZero comparison marketplace that lets you find and buy all your cybersecurity in one place.
- Symbiosis Pharmaceutical Services — Symbiosis Pharma is a biologics CMO offering rapid access to aseptic fill finish manufacturing slots across vaccines, ATMPs, mAbs & more
Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right companywith the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 82
- Round size: Seed $144k–$1.3M; Series A $1.7M–$25M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
- Chromacity — Chromacity manufacture the next generation of ultrafast lasers. Discover our fixed wavelength femtosecond lasers and picosecond OPOs.
- Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.
Midven is a specialist venture capital company providing investment to fast growing small and medium sized enterprises ("SMEs"), run by an energetic, experienced and hands-on team of investment managers.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 124
- Round size: Seed $152k–$1.7M; Series A $393k–$2M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $45M in 2018
Portfolio highlights
- Covatic — We help media companies deliver private-by-design, addressable advertising and marketing without exposing personal data.
- IDenteq — IDenteq provides software solutions for utility companies facing issues like non-notification, tenancy changes, and fraud. It offers a SaaS platform that enhances data management and security for energy suppliers. Identeq serves as an alternative to traditional credit reference agencies.
- Unloq AI — Unloq AI creates embedded, co-created technologies that link your business objectives to actual AI-enabled execution.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Empirical Ventures supports innovative approaches to critical problems in the fields of biotechnology and life sciences.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 35
- Round size: Seed $921k–$5.1M; Pre-Seed $1.1M–$1.6M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
- Optera —
- Neuronostics — At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored with the power of mathematical modelling
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 163
- Round size: Seed $249k–$3.9M; Pre-Seed $100k–$1.6M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Glaize — Made-to-measure stick-on gel manicures that are chip-free, long lasting and vegan. Easy to apply (just stick on), even easier to remove (simply peel off).
- Gigged.AI — Fill skill gaps using our on-demand talent network. Get AI-powered, real-time visibility over your employee and agent capabilities to power internal mobility.
- Product Guru — Although there has been a significant change of pace in the technology used within the retail sector, the process of finding the products that drive the market has really remained at a stand-still. With more and more small, specialist suppliers driving innovation in the sector, it has been harder than ever for buyers to be able to consider alloptions.
FSE C.I.C. is an independent not-for-profit Community Interest Company (C.I.C.) whose surpluses are reinvested in the business, rather than being driven by the need to maximise profit for shareholders and owners. FSE C.I.C. has a number of subsidiary companies to deliver its funds and services, which are collectively referred to as The FSE Group.All regulated activities are delivered through FSE Fund Managers Limited, which is authorised and regulated by the Financial Conduct Authority.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 198
- Round size: Seed $325k–$2.6M; Debt Financing $111k–$786k
- Lead/follow: 72% lead, 28% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Alvant — Alvant is an advanced materials technology group specialising in the design, development and production of aluminium composite components for demanding engineering applications.
- Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
- TruePlayers — Trueplayers is a computer game development company that specializes in mobile games. The company was founded in 2021 and is headquartered in Falmouth, Cornwall.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 194
- Round size: Seed $393k–$7.6M; Series A $2M–$23M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- AudioScenic — THE NEW DIMENSION IN SOUND
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 355
- Round size: Series A $3.2M–$21M; Venture - Series Unknown $4.4M–$22M
- Lead/follow: 83% lead, 17% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- Camino — Camino Leisure Holdings is a Spanish bar and restaurant that serves authentic food and wines.
- Gymbox — Making sweating enjoyable drives everything Gymbox does. From our unique exercise classes and nightly resident DJs, through to our larger than life personal trainers, at Gymbox there is undeniably a culture of fun.
- Nuada — MOF Technologies take innovative organisations from ideation to commercialisation using our proven MOF development expertise & patented technology.
KHP Ventures is an investment firm that provides innovative ideas for healthcare.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Sweden, Germany
Investor stats
- Total investments: 30
- Round size: Seed $1.4M–$6.5M; Series A $9M–$23M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- JAAQ — JAAQ helps organisations deliver trusted mental health support through governed content, guided journeys and measurable engagement.
- Klaris — Klaris automates the manual work medical device companies waste on regulatory documentation. Our first product is an AI Auditor with superhuman abilities.
- iFast Diagnostics — iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
xford Investment Consultants LLP ("OIC") advises Thompson Taraz, the Investment Manager of Oxford Technology and Innovations EIS Fund ("OTIF"). OIC is an Appointed Representative of Stoneware Captial LLP, which is authorized and regulated by the Financial Conduct Authority in the United Kingdom.The focus of OIC research ison University of Oxford spin out companies.Over the last fifteen years Oxford has produced a string of world-class spin-out companies. It is our belief that the next generation of world-class Oxford businesses is just waiting to be discovered.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Seed
- Geography: United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $982k–$7.6M; Series A $8M–$33M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Diffblue — Diffblue Testing Agent generates, verifies, and fixes unit tests autonomously across enterprise codebases.
- Panda Surgical — Panda Surgical is developing a next-generation handheld robotics platform that offers neurosurgeons enhanced dexterity and control in confined spaces, enabling more surgeons to perform complex minimally invasive procedures.
- Oxford Quantum Circuits — Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies.
We ensure that businesses in Northern Ireland with growth aspirations can access equity finance to reach their potential.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 68
- Round size: Seed $440k–$2.6M; Pre-Seed $735k–$1.5M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $17M in 2003
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- PathXL — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- LifeCellsNI — LifeCellsNI is committed to offering families and people throughout Northern Ireland and Ireland state-of-the-art stem cell extraction and storage services.
Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 42
- Round size: Seed $1.4M–$11M; Series A $1.6M–$47M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- Nami Surgical — Nami Surgical provides robotic surgery technology solutions to enhance patient care while giving surgeons intuitive, high-performance moveable instruments.
- Cumulus Oncology — Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need. We target key pathways to improve the efficacy and outcomes of current and experimental therapies. Cumulus has the backing of a successful entrepreneur in the oncology field and is led by a team of senior professionals and industry partners fromacross the drug discovery and development sector. Together, we offer a wealth of experience and deep insights into optimum approaches for improved cancer patient outcomes.
British Design Fund supports enterprise and innovation in the UK by investing in, and supporting, early-stage, well-designed, product businesses. The Fund works with extraordinary entrepreneurs with scalable products who are ready to accelerate growth and build long term value and thriving stand-out businesses.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, Germany
Investor stats
- Total investments: 47
- Round size: Seed $131k–$1.3M; Pre-Seed $131k–$1M; Venture - Series Unknown $190k–$650k
- Lead/follow: 72% lead, 28% follow
Portfolio highlights
- LabCycle — LabCycle is the world's first company to recycle hazardous plastic waste from laboratories (service) as well as the first to create 100% recycled laboratory consumables (product). Working with public and private labs, we are driving the circular economy of lab plastics to reduce the 5.5m tonnes of lab waste annually. A few highlights of ourprogress to date: • Proven impact - saving 90% of CO2 emissions & 93% energy compared to current alternatives: incineration and autoclave (LCA available upon request).• Technological validation creating the world's first 100% circular lab consumables including petri dishes, test tubes and more.• Secured commercial contracts with the NHS, several private companies and also universities. We are raising £1.5m to scale our patent pending technology to serve our growing demand after over 150+ organic expressions of interests following our feature in BBC news. The funding will establish the first automated decontamination system of our network, recycling over 350 tonnes annually, saving over 1000+ tonnes of carbon.
- SmartyPlants — SmartyPlants is an IT and Internet firm developing a plant sensory tool for the monitoring.
- Cordon Technologies — View our new Cordon Loop mixer that reduces pesticide and fertiliser usage by up to 40%.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We bring bold ideas to life to change the world for good.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 72
- Round size: Seed $982k–$2.2M; Series A $1.5M–$26M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $34M in 2014
Portfolio highlights
- Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
- Featurespace — Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countriesto prevent fraud and financial crime.ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
- Radio Physics Solutions — PASAR123 merupakan landasan utama bandar slot nomor 1 di indonesia memiliki fasilitas slot deposit pulsa tanpa potongan penarikan sangat mudah dan cepat.
Provided funding for early-stage businesses with innovative, scalable ideas but is now closed to new applicants.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 32
- Round size: Seed $506k–$8.6M; Pre-Seed $619k–$810k; Venture - Series Unknown $338k–$2M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- MySalesCoach — MySalesCoach offers Despite overwhelming evidence that sales coaching has the greatest impact on rep development and success, managers typically devote less than 5% of their time to coaching a team that craves and deserves coaching to reach their full potential.
- GNOSIS Health — Gnosis Health is a digital healthcare platform specializing in artificial intelligence and wearable technology for chronic disease management.
- Reform Studio — Reform Studio is a one-of-a-kind multi-floor location on Newcastle's famous Quayside that combines exercise and mindfulness to create a mind-body experience.
The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series B
- Geography: United Kingdom, France
Investor stats
- Total investments: 49
- Lead/follow: no public data
Portfolio highlights
- HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
- Sellmyartworks — EzelDotz - Buy and Sell Contemporary Art Online | Art Marketplace. Curated collection of Sculptures, Limited Editions and Originals.
- Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1821
- Round size: Seed $186k–$4.6M; Pre-Seed $108k–$755k; Series A $4.6M–$28M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Deja — Modern Rituals & Natural Products from the Ancient Science of Ayurveda
- Enoki Inc — Multiplayer-enabled tools for developers. Enoki has 18 repositories available. Follow their code on GitHub.
- Homethings — Single-use plastic is bonkers. Homethings makes cleaning products that make sense. No more shipping water in plastic bottles. We send non toxic cleaning tabs so that you can refill over and over again using your tap.
Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Angel
- Geography: United Kingdom, United States
Investor stats
- Total investments: 18
- Round size: Seed $458k–$880k
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
- DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
New Wave Ventures is a privately owned fund seeking the opportunity to invest for the long term in companies with significant growth potential. Their target initial investment is £500,000 to £2,000,000. They invest their own money without the need for external investors or borrowings. They are not driven by the need to service interest charges orto dispose of their investments by an artificial deadline. They do not believe in using leverage to boost their returns. They are willing to co-invest with like-minded investors, although their preference is to be the sole investor alongside owner-managers.
Show more...Investment focus
- Industry: Medical, Health Care, Internet
- Stage:Series A, Seed
- Geography: United Kingdom, France, Australia
Investor stats
- Total investments: 28
- Round size: Seed $1.3M–$26M; Series A $786k–$414M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Neubond — Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation.
- Neuronostics — At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored with the power of mathematical modelling
- Panda Surgical — Panda Surgical is developing a next-generation handheld robotics platform that offers neurosurgeons enhanced dexterity and control in confined spaces, enabling more surgeons to perform complex minimally invasive procedures.
Barwell is a privately-funded venture capital company that is based in Glasgow, Scotland.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: United Kingdom
Investor stats
- Total investments: 7
- Round size: Series A $3M–$4.3M; Series B $1.7M–$6.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MGB Biopharma — DropCatch.com helps you secure expiring domain names.
- Connect-In Ltd — Connect-In Ltd. stands for innovative Bluetooth IoT solutions, sustainable development, and state-of-the art design. Their sensors are built to be long lasting and power efficient (lasts 1-4 years on replaceable coin cell batteries) to make IoT understandable, accessible, and affordable, and to power the next generation of the Internet of Things.
- Lamellar Biomedical — Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.
Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.1M–$5M; Series A $2M–$32M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
- SenseAI —
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
The North West Fund is a £155m evergreen investment fund established to provide debt and equity funding to small and medium sized enterprises in the North West of England. The Fund will address an identified gap in the lending, venture capital and private equity markets.The Fund is managed by North West Business Finance Limited, an independentprivate sector company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States
Investor stats
- Total investments: 12
- Round size: Seed $131k–$262k; Series A $786k–$4.1M; Series B $1.3M–$2.5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Ulemco — Hydrogen dual fuel systems and zero-emission hydrogen solutions for transport and construction, supporting net zero commercial fleets.
- CynapseDx — CynapseDx develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from a neurodegenerative disease, such as alzheimer or parkinson disease. They engage in oligomeric and aggregated forms of protein biomarkers and have demonstrated that our assays can measure these forms of biomarkerproteins, when testing real patient blood samples.
- Perfectus Biomed — They are a microbiological services provider that provide our clients with a research based approach to microbiological testing, whilst recognising the client’s need for a rapid turnaround and a personalised service. We specialise in bespoke assays with a primary focus on biofilm testing.They appreciate that not all products are appropriate forstandard testing assays and therefore we work closely with our clients to develop methods that are suitable for the testing of novel products.They offer an extremely customer focused service that includes regular feedback, consultancy, method development and report writing. In addition we produce conference abstracts and posters based on the data we produce.
Volution is a UK based Venture Capital firm. We back ambitious Fintech and SaaS businesses, ready to accelerate their growth to Series B and beyond.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A, Series B
- Geography: United Kingdom, United States
Investor stats
- Total investments: 51
- Round size: Series A $643k–$9.8M; Series B $4.3M–$25M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Zopa — Zopa is a P2P money lending service that allows lenders and borrowers to deal directly with one another, cutting out the banks who act as middlemen. It works in the following way: the company first categorizes borrower credit grades with an A*, A, B, C, or Y rating; then lenders make offers that vary by money amount and time period for persons witha certain credit grade, and borrowers can then agree the aggregate offered rate.Zopa takes on such responsibilities as distributing money between parties, completing the legal paperwork, performing borrower identity/credit checks, and employing a collections agency that chases missed payments for the lender.Zopa also mitigates risk for lenders by enforcing monthly direct debit repayment, making borrowers sign a legal contract, and allowing lenders to lend small chunks of money to individual borrowers (i.e. someone lending £1000 would have their money spread across say, 100 borrowers).The company itself makes money by charging a fixed fee for borrowers and a 1% annual fee for lenders.Zopa has received public acclaim as well, having been awarded CNET Technology Awards' 2006 Internet Innovation of the Year, the 2007 Webby Award for Best Banking/Bill-Paying Website, the 2008 Webby Award for Financial Services, the Banker 2007 Award for Best Internet Project, and Moneywise 2009 Awards for Best Customer Service and Best Personal Loan.One of the three initial members of the UK's Peer-to-Peer Finance Association, together with FundingCircle and RateSetter. Other P2P lending services include
- DeadHappy — DeadHappy is an insurtech company that provides digital pay-as-you-go life insurance services. It specializes in offering flexible life insurance policies that are designed to be cheaper, easier, and better than existing traditional providers. Its offerings include pricing insurance based on current circumstances and the option to add furthercoverage on a rolling basis.The company was founded in 2013 and is headquartered in Leicester, England.
- Lightpoint Medical — Miniature, drop-in gamma probe system for minimally-invasive, robot-assisted cancer surgery.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MEIF is an investment firm that operates equity and debt investment towards growth capital. The firm aims to transform the finance landscape for smaller businesses in the Midlands and to realize the region’s potential to achieve economic growth through enterprise. It is a collaboration between the British Business Bank and ten Local EnterprisePartnerships (LEPs) in the West Midlands and East and South East Midlands. MEIF provides over £250m of investment to boost small and medium business (SME) growth in the Midlands.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Debt Financing, Seed
- Geography: United Kingdom, United States, Portugal
Investor stats
- Total investments: 122
- Round size: Seed $327k–$2.6M; Debt Financing $262k–$1.2M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- WELL Training — We deliver state of the art training solutions to national and international clients, transforming futures and delivering business growth through UK Apprenticeship and Commercial Training programmes.
- Utility Stream — As business energy brokers, USL was founded with one key mission, simplify business energy for all of our clients & help create a more sustainable world
- Silverback Gym Wear — Shop Silverback Gymwear the home of men's & women's gym clothes designed for strongman & bodybuilding. Exclusive artist designs & supreme quality gym clothing.
UK's leading investment service for high net worth and sophisticated investors. Tax-efficient investments, free guides, and exclusive investment opportunities.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 35
- Round size: Seed $1.1M–$5.9M; Series A $2M–$14M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Natrox — Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way.
- Viewture — Viewture uses statistics and analytics to help content creators find new ways to fund their work. Viewture was founded by David Page.
- Rise & Fall — We partner with the finest manufacturers to offer luxury womenswear, menswear and homeware without the premium price tag. We are B Corp certified.
Looking for an IoT investor for your start up or early stage company? Tern PLC is a venture capitalist working alongside ambitious entrepreneurs in the Internet of Things (IoT) space to deliver strategic IoT investment to grow your company.
Show more...Investment focus
- Industry: Software, Information Technology, Medical
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States
Investor stats
- Total investments: 21
- Round size: Seed $1.2M–$1.4M; Convertible Note $364k–$917k
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Konektio — Konektio is a dedicated M2M and IoT company which uses the best technology to deliver performance and solutions quickly and cost effectively. When you enquire we will need to visit you to discuss how to maximise the Konektio benefits for your particular business, whether OEM or End User, and also the type of devices (things) that you wish toconnect to. Our experience will help you to get the most out of any investment.
- FundamentalVR — Solutions for knowledge acquisition and skills development for any interactive medium
- Talking Medicines — Data Science for Life Sciences. Talking Medicines turns unstructured health data into actionable intelligence that proves real marketing impact.
SIS Ventures has been created with the overall aim of supporting and growing high impact organisations through access to mission-aligned investment. SIS Ventures has a goal of becoming the go to investor and partner for social entrepreneurs. The fund will offer conventional financial returns alongside social and/or environmental returns byinvesting either equity or debt into purpose driven companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.1M–$4.9M; Series A $2.8M–$19M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $1M in 2018
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
- Trojan Energy — Trojan Energy support the roll-out of its on-street flat and flush electric vehicle charging points, which aims to solve the issue for vehicle owners who do not have access to off-street parking.
Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Seed, Angel
- Geography: United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $79k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
- Novastone Media — Novastone enables instant chat across mobile and web to move customer conversations from email. Novastone’s white label chat solutions, built by financial industry experts, deliver on all these requirements, seamlessly moving organisations’ most valuable relationships from the inbox into a chat conversation.
- Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 178
- Round size: Seed $1.3M–$12M; Series A $6.3M–$49M; Series B $13M–$168M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $327M in 2022
Portfolio highlights
- AlveoGene — Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
- Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
We explore the rise of venture capital, plus the pros and cons of early-stage startups raising equity investment from venture capitalists.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 64
- Round size: Series A $6.5M–$28M; Series B $3.3M–$45M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Panthera Biopartners — Take part in paid clinical trials with Panthera Clinic. We run safe, professional medical research studies across the UK for a range of health conditions.
- ITD Global — The UK and international delivery experts for B2B. Choose ITD Global for ecommerce delivery, freight and parcel - your trusted partner.
- Socitm Advisory — Socitm Advisory is a management consulting firm that offers ERP, smart sourcing, DDaT, housing, and integrated care services.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 326
- Lead/follow: no public data
Portfolio highlights
- Amplience — The shopping experience platform for generating, creating and delivering content with context
- Orbex Space — Founded in 2015, Orbex is Europe’s leading private launch services company, focused entirely on supporting the needs of the small satellite industry.Orbex has developed one of the most advanced, low carbon, high performance micro-launch vehicles in the world. They launch customer satellites into polar and sun-synchronous low Earth orbits from aunique, modern launch location in the heart of the European continent.They offer a flexible core launch service and a wide suite of supporting services that make life easier for customers. Their European location means shorter supply lines, easier communications and reduced operational costs. Their advanced launch vehicle means higher reliability, more flexible mission profiles and a regular, scheduled launch service.
- ThreatMark — ThreatMark is the future of trust in the digital world. The company was founded with a vision of bringing trust to interactions across all digital channels through profound cyber security know-how and latest advancements in AI & Data Analytics. ThreatMark processes a comprehensive set of data inputs to continuously validate user’s identity& their intentions while protecting the user’s most valuable assets.At ThreatMark, we make sure that the entire digital journey (onboarding, authentication, account management, transactions…) is trusted and safe for both end-users and businesses. Major banks use ThreatMark’s deep behavioral profiling engine to analyze vast numbers of user specific data & behavioral traits to precisely identify legitimate users and deny fraudsters in real-time. For banks and their users, ThreatMark enables seamless digital experience that does not require additional authentication nor rely on simple transaction monitoring. ThreatMark goes beyond the industry standards to validate more than 25 million users and over 1 billion logins and transactions yearly.ThreatMark is shifting the paradigm in the digital world with advanced solutions complemented by a dedicated team of fraud specialists & cybersecurity experts working in our Security Operations Center (SOC), who vigilantly watch for new malicious activities throughout the digital landscape. Among various honors and industry recognition, ThreatMark has been recognized by Gartner as a Representative Vendor for the Online Fraud Detection area in its 2020 Market guide, named Deloitte’s Top Technology Fast 50 for CE; won 2019 AI Award – Company of the Year; and was awarded EY Entrepreneur of The Year for 2019.
Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity andcompelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Secondary Market
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 204
- Round size: Seed $700k–$5M; Series A $5M–$21M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- CameraMatics — Digitize fleet management to optimize performance. Onboard sensors, smart cameras, & apps to mitigate risk, manage safety & achieve sustainability goals.
- Modern Milkman — Modern Milkman is a Yorkshire-based milk delivery company.
- SURI (Sustainable Rituals) — A world-class clean that doesn’t cost our planet. SURI is the new, sustainable electric toothbrush. Delivering an effective clean with innovative plant-based materials.
The opportunity for institutional investors to access leading UK early stage healthtech businesses
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 130
- Round size: Seed $550k–$4.7M; Series A $3.2M–$13M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $2.8M in 2014
Portfolio highlights
- TidalSense — CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath.
- Baby2Body — Nearly 3 million women have used Baby2Body during their fertility, pregnancy, and postpartum journeys. Helping women around the world live healthier and happier with personalized fitness, nutrition, and wellness programs.
- Hummingbird Technologies — Hummingbird Technologies is an artificial intelligence SaaS platform using the latest deep learning and computer vision techniques along with proprietary algorithms to provide actionable intelligence to farmers and agri-businesses at key decision-making times in the growing season. The company analyses remote sensing data to help farmers identifyearly problems in their crops such as crop health, disease risk & detection, weed mapping and yield prediction as well as valuable information such as canopy coverage, plant counting, size and biomass estimation, with the objective of optimising inputs and maximising efficiency. Hummingbird began operating in 2016 and since then has covered in excess of >500,000 hectares of arable crops for farmers and agri-businesses. Their platform is utilised at key decision-making points in the growing season to allow intelligent and specific information to inform chemical or operational input decisions that decrease costs and improve outputs.
Medical Device Investor funding in United Kingdom at a glance
Stats across 845 deals from 765 investors.
Access all 765 investors in United Kingdom Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 765 investors investing in United Kingdom Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!